CHF - medicines; Congestive heart failure - medicines; Cardiomyopathy - medicines; HF - medicines
Most people who have heart failure need to take medicines. Some of these medicines are used to treat your symptoms. Others may help prevent your heart failure from becoming worse and let you live longer.
You will need to take most of your heart failure medicines every day. Some medicines are taken once a day. Others need to be taken 2 or more times daily. It is very important that you take your medicines at the right time and in the way your doctor has told you.
Never stop taking your heart medicines without talking to your health care provider first. This is also true for other medicines you take, such as drugs for diabetes, high blood pressure, and other serious conditions.
Your provider may also tell you to take certain medicines or change your doses when your symptoms get worse. Do not change your medicines or doses without talking to provider.
Always tell your provider before you take any new medicines. This includes over-the-counter medicines such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn), as well as drugs such as sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis).
Also tell your provider before you take any type of herb or supplement.
ACE inhibitors (angiotensin converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) work by opening blood vessels and lowering blood pressure. These medicines can:
Common side effects of these drugs include:
When you take these medicines, you will need to have blood tests to check how well your kidneys are working and to measure your potassium levels.
Most of the time, your provider will prescribe either an ACE inhibitor or an ARB.
A new drug class called angiotensin receptor-neprilysin inhibitors (ARNI's) combines an ARB drug with a new type of drug. Entresto (Sacubitril/Valsartan) has gained prominence and risen in some guidelines to the same level as ACE inhibitors or ARBs.
Another new drug class called sodium-glucose cotransporter-2 (SGLT-2) inhibitors were developed to treat diabetes. However, they have been found to help in some people with heart failure and are being more widely used for this purpose. Examples of these medicines are dapagliflozin (Farxiga) and empagliflozin (Jardiance).
Beta blockers slow your heart rate and decrease the strength with which your heart muscle contracts in the short term. Long term beta blockers help keep your heart failure from becoming worse. Over time, they may also help strengthen your heart.
Common beta blockers used for heart failure include carvedilol (Coreg), bisoprolol (Zebeta), and metoprolol (Toprol).
Do not abruptly stop taking these drugs. This can increase the risk of angina and even a heart attack. Other side effects include lightheadedness, depression, fatigue, and memory loss.
Diuretics help your body get rid of extra fluid. Some types of diuretics may also help in other ways. These drugs are often called "water pills." There are many brands of diuretics. Some are taken once a day. Others are taken 2 times a day. The most common types are:
When you take these medicines, you will need regular blood tests to check how well your kidneys are working and measure your potassium levels.
Coumadin (Warfarin) is recommended for people with heart failure who have a higher risk for blood clots. You will need to have extra blood tests to make sure your dose is correct. You may also need to make changes to your diet.
Drugs used less commonly for heart failure include:
Statins and other cholesterol-lowering drugs are used when needed.
Antiarrhythmic medicines are sometimes used by heart failure people who have abnormal heart rhythms. One such drug is amiodarone.
Another medicine, Ivabradine (Corlanor), acts to lower the heart rate and may help people with heart failure by reducing the heart's workload.
Maddox TM, Januzzi JL Jr, Allen LA, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77(6):772-810. PMID: 33446410 pubmed.ncbi.nlm.nih.gov/33446410/.
Mann DL. Management of patients with heart failure with reduced ejection fraction. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier Saunders; 2019:chap 25.
Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/ AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Cardiac Failure. 2017;23(8):628-651. PMID: 28461259 pubmed.ncbi.nlm.nih.gov/28461259/.
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240-e327. PMID: 23741058 pubmed.ncbi.nlm.nih.gov/23741058/.BACK TO TOP
Review Date: 5/8/2021
Reviewed By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2021 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.